Risk-adapted, MRD-directed Therapy for Young Adults With Newly Diagnosed Acute Myeloid Leukemia
Clinical trial NCT01452646 · COMPLETED
Trial details
- NCT number
- NCT01452646
- Sponsor
- Gruppo Italiano Malattie EMatologiche dell'Adulto
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-01-01
- Primary completion
- 2017-07-01
- Enrollment
- 515
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.